IMMUNOLOGY
1. Kupffer cell- liver MF
2. Abs- 2 Heavy chains, 2 light chains
oFc portion = same/constant for all Abs in same class. c’ proteins bind here on IgG and IgM***
oIgG- 75%, valence = 2
oIgM- 14%, 1st responder, forms pentamer via J chain, valence = 10, found in active dz
oIgA- 8%, mucosal lymph nodes, 1° Ab in tears, can form dimer, valence = 4
oIgE- 1-2%, Valence = 2, not free in blood, involved w/ allergies/parasites
3. MHC 1
oChromosome 6 encodes MHC/HLA. Present on almost all host cells + APCs (MFs, B cells, Dendritic cells, PMNs,
Langerhan cells). Absent in RBCs and some neurons. Self-recognition, recognized by CD8 TC. Referred to as HLA in
autoimmune Dz
4. MHC 2
oFound on Thymic epithelial cells *BOARDs* and APCs. APCs bind Ags to MHC 2 to present to CD4 of TH1 and TH2
5. Diapedesis - WBCs squeezing through endothelial cells
6. INNATE MMUNITY
oSKIN, Stomach acid, mucousal membranes w/ Lysozymes. Monocytes (in blood) arrive after granulocytes (PMNs) and become
Mfs (upon entering tissue)
oIFNs α, IFN β- produced by virally infected cells to warn neighboring cells to stop protein replication (halts virus replication)
oIFN γ- produced by Lymphocytes, Natural Killer cells to STOP CANCER / TUMOR growth *BOARDs*
oIFN α Tx- Hep C, Hairy-cell leukemia, Kaposi Sarcoma
oIFN β Tx- Relapsing MS **TEST**
oIFN γ Tx- Chronic granulomatous Dz (TB, Sarcoidosis)***
oNatural Killer (NK) cells- Non-specific Lymphocytes, 1st line of defense against TUMORs *BOARDs*, No Ag recognizing
site / APC used, Viral/Tumor protection
oOpsonization- Abs bind to Ags and flag for phagocytosis
oc’ Functions- activated by Ab-Ag complex (1)Direct lysis (2)Chemotaxis of PMNs/MFs (3)Opsonization (4)Degranulate
Mast Cells (↑Histamine) to ↑Diapedesis
i. c’-1 located / produced in cornea and concentrated in periphery near conj vessels w/ IgG
ii. c’ Classic Pathway
1. IgG / IgM form Ab-Ag complex c’-1 binds Fc portion of IgG / IgM c’-1 cleaves c’-4 c’-4 cleaves c’-2
MAC (Membrane Attack Complex ) is formed on membrane of Ag and lysis occurs
iii. c’ Alternative Pathway- activation of c’ by IgA/Bacterial ENDOTOXINS initiate process
7. ADAPTIVE IMMUNITY
oB-cell activation- 2 methods (1) Ag binds directly to Surface IgM or IgD on B cell. (2) TH2’s CD4 binds B Cell’s MHC 2
and TH2 secretes IL-4 to stimulate B cell
oTC (CD 8)- binds infected cells/tumor cells via MHC 1. Responsible for Transplant rejection
oAPCs = B cells, MFs, PMNs, Monocytes (in blood)
oTH1 – cellular immunity, only communicates w/ APC’s (excluding B cells) MHC 2 receptor via TH1’s CD4
i. IL-2 - TH1 growth factor RESTASIS inhibits IL-2 Production **TEST**
ii. IL-3 - Multi-colony stimulating factor (widespread growth of Myeloid (PMNs, MFs, etc) in BM)
iii. IFN-γ - ↑MF activity, ↓TH2 activity
iv. CD40 Ligand
oTH2 – humoral immunity, stay in lymph node to activate B cells
i. IL-4 - TH2 growth factor, ↑B cell activity, ↓ TH1 activity
ii. CD40 Ligand
oMF + DCs
i. IL-12 - Tells T0 cells to ↑ TH1 differentiation
ii. IL-4 - Tells T0 cells ↑TH2 differentiation
oTC (CD 8)
i. Fas ligand- triggers apoptosis
ii. Cytotoxins (Perforins- make holes, Granzymes- causes DNA damage)
iii. IFN-γ - ↑MF activity, ↓TH2 activity
oTreg/suppressor, NKT, Breg
i. IL-10 - suppresses IR after pathogen cleared, ↑TH1 apoptosis
ii. TGF-β
oMF at infection site
i. IL-1 - energize MFs, ↑inflammation, FEVER, ↑platelet
ii. IL-6 - Fever, Chemotaxis, Lectin-mediated c’ pathway
iii. IL-8 - Chemoattractant (major)
oPMNs
i. Lactoferrin – binds Fe
oLT- chemotactic agent for MFs and PMNs, ↑mucous production from Goblet cells, ↑VP
8. 1° Exposure- 5-10 days to response w/ measurable Abs, IgM made first
9. 2° Exposure- Fast response, <2 hrs to produce Abs, IgG made first **TEST**
10. TISSUE TRANSPLANT REJECTION- TC cells attack tissue via Type 4 Hypersensitivity
oHYPERACUTE REJECTION- within mins, Ab-mediated because recipient had preformed Abs against donor tissue
oACUTE REJECTION- Weeks after, T cell-mediated due to foreign MHC rejection
oCHRONIC REJECTION- Mos-yrs after, Ab-mediated and IRREVERSIBLE
11. IMMUNOLOGICAL TEST
oESR- 1 hr non-specific inflammatory test